Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

@article{Ario2016AntiLGI1associatedCI,
  title={Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.},
  author={Helena Ari{\~n}o and Tha{\'i}s Armangu{\'e} and Mar Petit-Pedrol and Lidia Sabater and Eugenia Mart{\'i}nez-Hern{\'a}ndez and Makoto Hara and Eric Lancaster and Albert Saiz and Josep Dalmau and Francesc Graus},
  journal={Neurology},
  year={2016},
  volume={87 8},
  pages={759-65}
}
OBJECTIVE We investigated a series of patients with LGI1 antibody (Ab)-related cognitive deterioration to determine the clinical presentation, long-term outcome, and LGI1 Ab evolution. METHODS We retrospectively analyzed the clinical information of 76 patients with LGI1 Ab-related cognitive deterioration. Presenting syndromes were classified as limbic encephalitis (LE), non-LE, or encephalopathy (normal MRI and no CSF pleocytosis). Frequency of relapses and clinical outcome were assessed in… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 12 times over the past 90 days. VIEW TWEETS